Back to top
more

Hims & Hers Health (HIMS)

(Delayed Data from NYSE)

$55.52 USD

55.52
105,745,307

-7.83 (-12.36%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $56.22 +0.70 (1.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is First Trust Mid Cap Core AlphaDEX ETF (FNX) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FNX

Zacks Equity Research

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNX

Zacks Equity Research

Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know

by Zacks Equity Research

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.23, denoting a +1.57% change from the preceding trading day.

Zacks Equity Research

Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up

by Zacks Equity Research

BRKR's new 1.3 GHz high-resolution NMR system comes with a stable, standard-bore 54 mm superconducting magnet.

Zacks Equity Research

Is Invesco S&P SmallCap Quality ETF (XSHQ) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XSHQ

Zacks Equity Research

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM

by Zacks Equity Research

TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.

Zacks Equity Research

Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?

by Zacks Equity Research

BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.

Zacks Equity Research

Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

by Zacks Equity Research

BIO continues to attract investors' attention due to its robust performance in the ddPCR platform.

Urmimala Biswas headshot

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

by Urmimala Biswas

In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.

Zacks Equity Research

LH Stock to Gain From Launch of HPV and STI Self-Collection Options

by Zacks Equity Research

Labcorp launches self-collection options for HPV and STI testing in its PSCs.

Zacks Equity Research

Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SLYG

Zacks Equity Research

Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNY

Zacks Equity Research

Company News for Apr 2, 2025

by Zacks Equity Research

Companies In The News Are: PVH, PRGS,RBLX, GOOGL, HIMS, LLY.

Zacks Equity Research

ABT Stock to Gain From Early CE Mark Approval of Volt PFA System

by Zacks Equity Research

Abbott achieves early CE Mark approval for the Volt PFA system.

Zacks Equity Research

Is This the Right Time to Hold ALGN Stock in Your Portfolio?

by Zacks Equity Research

Align Technology continues to attract investors' confidence thanks to its share gains in the malocclusion market and strategic deals.

Zacks Equity Research

Should Invesco S&P SmallCap Quality ETF (XSHQ) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for XSHQ

Zacks Equity Research

Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $29.55, representing a +1.41% change from its previous close.

Zacks Equity Research

Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock

by Zacks Equity Research

TMO and CZ Imaging Institute to collaborate on further understanding of human cells.

Zacks Equity Research

International Expansion, Product Launches Support BSX Stock

by Zacks Equity Research

Boston Scientific continues to successfully expand its operations across various geographies outside the United States.

Zacks Equity Research

Is Quest Diagnostics Stock Worth Holding Onto Right Now?

by Zacks Equity Research

Strong momentum in Advanced Diagnostics and strategic acquisitions continues to attract investors to DGX.

Zacks Equity Research

National Vision Stock Rises 28.2% YTD: Will the Rally Continue?

by Zacks Equity Research

EYE's strength in its largest brand and actions to achieve a healthier store fleet position the stock favorably.

Zacks Equity Research

Hims & Hers Health (HIMS) Down 7.1% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Is This the Right Time to Hold Integra Stock in Your Portfolio?

by Zacks Equity Research

IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.